Peter Hilgard
- Molecular Biology
- Public Health, Environmental and Occupational Health top 10%
- Oncology
- Epidemiology
- Organic Chemistry
- Co-authors
- Jurij StekarR. VoegeliShyam SundarM K MakhariaAshish GoyalHenry W. MurrayF. RosenkaimerAndreas Voß
- Topics
- PI3K/AKT/mTOR signaling in cancer (4 papers)Chemotherapy-induced organ toxicity mitigation (3 papers)Blood properties and coagulation (2 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Peter Hilgard
32 papers receiving 703 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 286
- Public Health, Environmental and Occupational Health 227
- Oncology 125
- Epidemiology 123
- Organic Chemistry 96
Countries citing papers authored by Peter Hilgard
This map shows the geographic impact of Peter Hilgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hilgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hilgard more than expected).
Fields of papers citing papers by Peter Hilgard
This network shows the impact of papers produced by Peter Hilgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hilgard. The network helps show where Peter Hilgard may publish in the future.
Co-authorship network of co-authors of Peter Hilgard
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hilgard. A scholar is included among the top collaborators of Peter Hilgard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hilgard. Peter Hilgard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 40 | |
| 3 | 192 | |
| 4 | 19 | |
| 5 | 12 | |
| 6 | 4 | |
| 7 | 29 | |
| 8 | 2 | |
| 9 | 27 | |
| 10 | 16 | |
| 11 | 2 | |
| 12 | 12 | |
| 13 | 50 | |
| 14 | 3 | |
| 15 | 9 | |
| 16 | 24 | |
| 17 | 3 | |
| 18 | 92 | |
| 19 | 20 | |
| 20 | 31 |
About Peter Hilgard
Peter Hilgard is a scholar working on Hematology, Critical Care and Intensive Care Medicine and Pharmaceutical Science, having authored 32 papers that have together received 747 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Blood properties and coagulation (2 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (227 citations), Hematology (78 citations) and Parasitology (44 citations). Peter Hilgard has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Jurij Stekar, R. Voegeli, Shyam Sundar, M K Makharia, Ashish Goyal, Henry W. Murray, F. Rosenkaimer, Andreas Voß, Clemens Unger and Jürgen Engel. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.